Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease.
Assessment of the clinical severity of Fabry disease (FD), an X-linked, rare, progressive disorder based on a genetic defect in alpha-galactosidase is challenging, especially regarding cardiac involvement. The aim of the study was to evaluate the diagnostic value of cardiac troponin I (cTnI) in disc...
Main Authors: | Christian Tanislav, Dursun Guenduez, Christoph Liebetrau, Anne Kathrin Giese, Sabrina Eichler, Nicole Sieweke, Maria Speth, Timm Bauer, Christian Hamm, Arndt Rolfs |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4913911?pdf=render |
Similar Items
-
Continuous cardiac troponin I release in Fabry disease.
by: Andreas Feustel, et al.
Published: (2014-01-01) -
Persistent increase in cardiac troponin I in Fabry disease: a case report
by: Schneider Christian, et al.
Published: (2011-01-01) -
Cardiac Troponin I elevation after epileptic seizure
by: Sieweke Nicole, et al.
Published: (2012-07-01) -
Clinical Utility of Cardiac Troponin I and Cardiac Troponin T Measurements
by: Michaela Adamcová, et al.
Published: (1997-01-01) -
Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?
by: Tobias Böttcher, et al.
Published: (2013-01-01)